A South Wales woman, Rachel Cooper, says she began using Mounjaro (tirzepatide) to lose weight after gaining extra pounds during the Covid-19 period. In her account, she had also been drinking alcohol and taking cocaine and described those behaviours as ones she felt ashamed of and tried to hide. She says that after starting the weight-loss injections, she noticed changes not only in her appetite and weight but also in her desire to drink and use drugs. The reports describe her experience as “astonishing,” portraying the medication as having a broader effect on her habits than weight loss alone. The available information is based on her personal testimony and does not provide independent confirmation of the causes of changes in substance use. The articles focus on her claim that Mounjaro coincided with a reduction in alcohol and cocaine use following her decision to seek help for weight control.